Literature DB >> 8242888

Biochemical tests in the diagnosis of chronic pancreatitis and in the evaluation of pancreatic insufficiency.

D M Goldberg1, P R Durie.   

Abstract

Chronic pancreatitis (adults) and cystic fibrosis (children) are the most common diseases leading to exocrine pancreatic insufficiency that, when reduced to < 5% of normal function, is characterised by steatorrhoea. The pathogenesis of the former condition is outlined, and recent concepts are emphasized. Biochemical tests to detect pancreatic insufficiency and to identify pancreatic disease as the cause of steatorrhoea include: serum enzyme tests (lipase, amylase, trypsin); stool chymotrypsin; isotopic tests based upon the assimilation of [14C] lipids and starch or excretion of the isotope as breath CO2, as well as the dual-labelled Schilling test; oral function tests utilising substrates hydrolysed by pancreatic enzymes such as benzoyl tyrosyl-p-aminobenzoic acid and fluorescein dilaurate; and duodenal intubation studies following meal-induced or hormonal stimulation of the pancreas. The rationale for these tests and the cumulative clinical experience of their utility are reviewed. A recommended diagnostic strategy is briefly presented. The role of various biochemical procedures to evaluate the efficacy of pancreatic enzyme replacement therapy is also described.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8242888     DOI: 10.1016/0009-9120(93)90124-o

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  3 in total

1.  Thirteen cystic fibrosis patients, 12 compound heterozygous and one homozygous for the missense mutation G85E: a pancreatic sufficiency/insufficiency mutation with variable clinical presentation.

Authors:  C Vazquez; G Antiñolo; T Casals; J Dapena; J Elorz; J L Seculi; J Sirvent; R Cabanas; C Soler; X Estivill
Journal:  J Med Genet       Date:  1996-10       Impact factor: 6.318

2.  Can We Detect Chronic Pancreatitis With Low Serum Pancreatic Enzyme Levels?

Authors:  Chang-Il Kwon; Hong Joo Kim; Paul Korc; Eun Kwang Choi; Gail M McNulty; Jeffrey J Easler; Ihab I El Hajj; James Watkins; Evan L Fogel; Lee McHenry; Michelle K Zimmerman; Stuart Sherman; Glen A Lehman
Journal:  Pancreas       Date:  2016-09       Impact factor: 3.327

Review 3.  Drug management of noninfective complications of cystic fibrosis.

Authors:  I Sanchez; E Guiraldes
Journal:  Drugs       Date:  1995-10       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.